Employees using psychoactive substances are more likely to be less productive, change jobs frequently, file workers’ compensation claim, meet with accidents, and develop absenteeism. Brief interventions (BIs) are considered effective in limiting substance use in various health and workplace settings. World Health Organization (WHO) developed a comprehensive package named WHO alcohol, smoking, and substance involvement screening test (ASSIST)-linked brief intervention (ALBI) to tackle such issues. ALBI is based on components of BI from the feedback, responsibility, advice, menu of options, empathy, self-efficacy (FRAMES) model and motivational interviewing, and it has convincing research support for its efficacy.[3-10] Yet, empirical data on screening and BI in the workplace are limited, especially for ALBI.[11-14] Currently there is no randomized controlled trial from India using ALBI to reduce risky substance use (not only alcohol) in the workers employed in a tertiary care hospital.[12-16]
The present study was conducted to assess the efficacy of ALBI to reduce risky patterns of substance use in Class C male workers at a tertiary-care hospital setting, to enhance the progress of the participants through the stages of change, and to improve their QOL.
Research design and setting
A randomized controlled trial (RCT) design was followed. Standards described in the consolidated standards of reporting trials (CONSORT) were followed, using CONSORT checklist and CONSORT flow diagram. The study was carried out in the workplace setting among Class C male workers. These workers are skilled and semi-skilled manual workers such as hospital and sanitary attendants, library attendants, cleaners, security guards, etc., employed at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sample size calculation
Sample size estimation was based on ASSIST scores from a previously published pilot study from our center, which used a pre–post design but no control group. The mean preintervention ASSIST score was 26.55 (SD = 6.54) and at 4-month follow up the mean postintervention ASSIST score was 20.06 (SD = 7.84). With these data, we calculated that 27 participants would be required in each of the intervention and the control group to achieve a significance level of 0.05 and power of 90%. Adjusting for an estimated 20% dropout at 3 months, the final intake samples in each group for the RCT were 35. Accordingly, the total screen positive sample size for RCT was 70. Our previous study found that approximately 25% of the Class C male workers screened with ASSIST were “screen-positive” (i.e., at moderate and severe risk for harmful alcohol use). Hence, the number of subjects from the population to be screened for obtaining 70 screen-positive subjects was four times; that is, 280 (rounded off to 300) Class C male employees were needed to be screened with ASSIST or till the requisite number of 70 was reached. The actual number of subjects screened were even more because some screen-positive subjects declined to undergo ASSIST screening or to provide informed consent even if found screen-positive. Hence, considering a 25% refusal rate, the final number of subjects from the population of Class C male hospital employees to be approached for screening came to 400. Thus, a list of 400 was generated from the entire population of Class C male hospital employees (both permanent and on contract) by computer-based random number generator. (Source for sample size calculation: http//:sampsize.sourceforge.net).
The participants were 20 to 60 years old male workers of PGIMER Chandigarh who were ASSIST screen positive and provided informed consent to participate in the study. Participants were excluded if they had severe communication difficulties (language problems, deafness), were intoxicated or in severe withdrawal at the time of assessment (however, these latter subjects were again approached later, and included if they were willing), were already undergoing treatment for substance use disorders, had comorbid severe physical or mental illness which could interfere with assessment, or were otherwise uncooperative or unwilling to participate in the study.
The study was conducted in two phases. In Phase I, a list of 400 such employees was drawn from by computer-generated random numbers fulfilling the inclusion criteria. The sample was screened using the ASSIST V3.0, and on the basis of their scores the participants were graded into three risk categories: low, moderate, and high level of risk. The moderate- and high-risk subjects (‘ASSIST Screen Positive’) for use of any substance, alone or in combination, constituted the study population for the Phase II of the study. In Phase II, 70 ASSIST Screen positive and consenting participants were randomly recruited from this ASSIST screen positive pool. This constituted the study sample for intervention. These ASSIST Screen-positive subjects were first administered the following research instruments: Socio-demographic performa, clinical performa (these two are routinely used in our department for assessment purpose), readiness to change questionnaire (RCQ) and WHO quality-of-life scale, brief version (WHOQOL-BREF), Hindi version. Next, they were randomized into an intervention group and a control group by permuted block randomization using a computer-generated procedure. After randomization, the intervention group was administered WHO ALBI package (single session of 15–30 min) as a structured and individualized therapy provided immediately after the assessment. The assessments and the ALBI session was conducted by the principal author. The session consisted of discussing individualized harmful consequences of using substance, establishing clear link between substance consumption and the consequences, emphasizing the patient’s personal responsibility to change, evaluation of high-risk situations, implementation of alternative highs, advice on coping strategies and facilitating self-efficacy and optimism. It also included advice for proper specialized consultation if needed.
In the control group, an individualized session of about 15–30 min was conducted by the same investigator immediately after the assessment. It included general health information, advice to cut down or stop substance use, take-home pamphlets on substance use and referral to specialized treatment centers if needed.
In the final stage, a follow-up assessment was done 3 months after the intervention by contacting all the participants at their workplace by the same investigator. The re-assessment included all the initial assessment tools (ASSIST, RCQ, and WHOQOL-BREF) in both the groups.
Analysis was done using the SPSS version 21.0 for windows (Chicago, Illinois, USA) by using descriptive and inferential statistics. Means, standard deviations and percentages were used for descriptive statistics. Bonferroni correction was done for multiple comparisons. For inferential statistics, two-way repeated-measures ANOVA using ASSIST Score as the variable was used to determine if the two groups differed from each other (“Main effects”) as well as to study any interaction between group and time (“Interaction effect”). Any significant baseline intergroup differences were adjusted in the statistical model. Similar procedure was used to enhance the progress of the participants through the Stages of Change. Chi-square test was used for comparing the frequency of treatment seeking in the two groups.
Selection of sample
The study was conducted from July 2015 to December 2016. Confidentiality of the participants was ensured. The participants, interventions and flow details are summarized in the CONSORT flowchart depicted in Figure 1. Among the 400 workers, 360 participated in the study. Of these participants, 324 (90%) were ASSIST positive for any level of substance use involvement including low level of risky use. The prevalence of those with moderate or high-risk use (the ASSIST “Screen positive”) was 112 (31.1%) for any substance [103 for tobacco (28.6%), 99 for alcohol (27.5%), and 25 for cannabis (6.9%)]. These were not exclusive numbers because many scored screen-positive for multiple substances [Table 1]. Out of these 112 ASSIST screen-positive participants, a total of 70 subjects who consented for the RCT were recruited for intervention. They were randomized into intervention and control groups, with 35 participants in each group.
Demographic profile of Intervention and Control groups shows that the mean age (±SD) of participants of control group was 36.69 (±9.44) years (range 25 to 56) and that of intervention group was 38.74 (±9.68) years (range 27 to 55). Baseline substance use related data are shown in Table 2. Risk level, RCQ scores and QOL of randomized groups at Baseline. Distribution of subjects according to their substance use profile at baseline in both control and intervention group are shown in Table 3. It show majority of the participants are consuming alcohol and tobacco in combination with small percentage were used either tobacco or alcohol along (none were using cannabis alone) However they did not differ significantly in distribution of substance using pattern (p=0.391; X2=4.112).
ASSIST-based risk stratification
Most of the participants scored high on ASSIST and were categorized at high-risk level (the numbers for tobacco, alcohol, and cannabis were 27, 26, and 6, respectively, in the control group, and 29, 30, and 6, respectively, in the intervention group; the remaining participants were in the moderate risk category).
Stage of change on the basis of RCQ at baseline
RCQ, applied to assess the current stage of change, showed that most of the participants were at precontemplation and contemplation stages. The numbers of participants in the precontemplation and contemplation stages in the intervention and control groups were 21, 13 and 19, 15, respectively, for tobacco use; 11, 12 and 19, 20, respectively for alcohol use, and 3 each in both the groups for cannabis use.
Quality-of-Life of randomized groups at baseline
The mean total WHOQOL scores were 70.54 (±5.96) and 73.11 (±6.73) for the control and intervention groups, respectively. The mean scores for physical health domain were 20.04 (±2.26) and 20.74 (±2.22), for psychological health 14.82 (±2.58) and 15.14 (±2.14), for social relationship domain 9.35 (±1.15) and 9.82 (±1.33), for environmental domain 18.88 (±4.52) and 19.88 (±2.75), and for general health domain 7.64 (±0.34) and 7.82 (±0.17) in these two groups. The mean time ± SD (and range) spent on general talk and ALBI was 28.9 5 ± 1.4 (25–30) and 29.61 ± 0.83 (25.5–30) min in the control group and intervention groups respectively. ASSIST scores with risk level, RCQ and QOL of groups at 3-month follow-up after intervention.
ASSIST scores were compared at baseline and follow-up for both control and intervention groups, with the control group serving to control for the effects of time and to determine if there was a significant interaction effect. Two-way repeated measures ANOVA showed a significant reduction of mean tobacco ASSIST scores over time among the groups (F = 218.95, P < 0.001, observed power 100%), and a significant reduction in mean scores among the groups (F = 31.40, P < 0.001, observed power 100%).
Furthermore, there was a significant interaction effect in that the group receiving the BI at baseline which had significantly lower mean tobacco ASSIST scores at follow-up compared to the control group (F = 104.34, P < 0.001, observed power 100%). Similarly, there was a statistically significant reduction of mean alcohol and cannabis ASSIST scores over time among the groups (F = 482.06, P < 0.001, observed power 100% and F = 92.87 P = 0.001, observed power 99.8%, respectively). There was also a significant reduction in mean scores among the groups using alcohol and cannabis (F = 48.3, P < 0.001, observed power 100% and F = 30.26, P < 0.001, observed power 99.3%, respectively). Additionally, there was a significant interaction effect and the group receiving the BI at baseline which had significantly lower mean alcohol and cannabis ASSIST scores (F = 246.16, P < 0.001, observed power 100% and F = 25.11, P < 0.001, observed power 99.3%, respectively) [Table 4 and Figures 2-4].
Stages of change
At 3-month follow up there was no subject at precontemplation stage in intervention group compared to control group for tobacco, alcohol, and cannabis use. Most of the subjects had progressed to action stage in the intervention group compared to the control group. The changes were statistically significant for risky tobacco, alcohol, and cannabis use when the groups were compared at follow-up with respect to their base line (P < 0.001; P < 0.001; P = 0.007), respectively [Table 5].
Two-way repeated measures ANOVA results showed a significant increase in total WHOQOL- BREF scores over time among the groups (F = 172.93, P < 0.001, observed power 100%), and there was a significant increase in scores among the groups (F = 44.12, P < 0.001, observed power 100%). Further, there was a significant interaction effect and the group receiving the BI at baseline had significantly higher mean total WHOQOL-BREF scores at follow-up compared to the control group (F = 25.66, P < 0.001, observed power 99.9%) [Table 5]. Similarly, significant increase in scores in physical health, psychological health, social relationship, environmental and general health domains of WHOQOL-BREF was recorded over time among the groups (F = 65.38, P < 0.001, observed power 100%; F = 98.84, P < 0.001, observed power 100.
%; F = 78.92, P < 0.001, observed power 100%; F = 112.09, P < 0.001, observed power 100%; F = 29.56, P < 0.001, observed power 100%, respectively). There was also a significant increase in scores in all domains of the WHOQOL-BREF among the groups. Additionally, there was a significant interaction effect and the group receiving the BI at baseline had significant increase in scores in all the domains of WHOQOL-BREF (F = 4.50, P < 0.038, observed power 55.1%; F = 21.35, P < 0.001, observed power 95.5%; F = 8.67, P < 0.005, observed power 82.6%; F = 34.04, P < 0.001, observed power 100%; F = 10.52, P < 0.002, observed power 89.2%, respectively) [Table 6].
Efficacy of ASSIST-linked BI in motivating the subjects to seek treatment and its comparison with control group
In the control group only 4 (11.4%) out of 35 screen-positive subjects were motivated to seek treatment whereas in the intervention group 12 (34.35%) out of 35 screen-positive subjects were motivated to seek treatment (P = 0.023).
This RCT showed that a single-session ALBI improved the risk scores for alcohol, tobacco, and cannabis use in male employees working in a health care setting, propelled more participants to an action stage of change and seeking help, and enhanced their QOL in all domains, compared to nonspecific general intervention, over a 3-month period. Although our study screened for many substances of use by the workers (illicit and licit) as listed in ASSIST, only tobacco, alcohol, and cannabis were reported. Tobacco and alcohol are legal substances (with certain regulations of use) and, hence, they do not come under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Acts 1985, Government of India. NDPS Act banned the production and sale of cannabis resin and flowers, but permitted the use of the leaves and seed, allowing the states to regulate the latter.
The prevalence of moderate-to-high-risk use of tobacco, alcohol, and cannabis in the total sample was 28.6%, 27.5%, and 6.9% respectively. These figures raise serious concern, but are in line with the two available studies in the workplace settings from India, one of which found 21% industrial workers with hazardous drinking, and another study found about 27% industrial workers using any substance.
Maximum participants used tobacco in combination with alcohol [67 (59.8%) among ASSIST “screened positive” subjects]. This finding was in line with several studies which stated that there exists a strong association between tobacco use and alcohol and illicit substance use sharing common identifiable risk factors.[23,24]
The feasibility and active involvement in the sessions were similar to that in another study which used face-to-face interview in workplace. It suggests that the workplace is amenable to screening and active participation for BI using face-to-face intervention.
Only 7.14% of our subjects dropping out (3 out of 35 in control group and 2 out of 35 in intervention group after the 3-month interval) was in line with another study in a community-based sample from north India. The low attrition in our study could be due to the same investigator conducting the study at the work place, and in a short-time span of 3 months.
Two-way repeated measure ANOVA indicated statistically significant differences between the groups over the 3-month follow-up on the mean total ASSIST tobacco, alcohol, and cannabis scores. Compared to the controls, the ALBI participants had significantly reduced scores for all measures, indicating that ALBI was more effective than the general talk in getting the participants to reduce their risky substance use. This concurs with many other studies done at workplace and other setups in India and elsewhere.[12,15,16,25-29] Interaction effects at risk level indicate that as compared to the controls the ALBI group had significant reduction of risk level of tobacco, alcohol, and cannabis use. The reason may be that in our study we delivered ALBI directly after screening. This was in keeping with the recommendation that the time gap between screening and intervention should be minimal, and that time being a “teachable moment” when patients have heightened receptivity to recommendations for reducing substance use. Intervention effects on stage of change as per the RCQ indicate that significantly more ALBI group subjects had moved on to action stage than the control group subjects. Possibly the structured ALBI helps them to appreciate their tobacco and alcohol use related problems and motivates them to change their thinking and behavior more than that achieved by a general talk. This is in line with an earlier similar study, where a 1-hour motivational intervention produced a more positive shift in a stage of change than in the educational group. However, in the people who use cannabis in risky pattern in our study, the interaction effects indicated no significant change in the contemplation stage in both groups but significant changes in pre contemplation and action stages in the intervention group compared with control group. This could be due to the small number of subjects using cannabis at risky level. Interaction effects showed statistically significant differences between the groups over the 3-month follow-up on the mean total as well as all the domains of WHOQOL-BREF scores. The ALBI participants had significantly better scores in all the domains compared to control group participants, indicating that the structured BI was more effective compared to general talk given to control group in improving their QOL; this was in line with the previous community based study form north India.[25,32,33]
More participants in the intervention group (12 vs. 4) sought treatment for substance use disorders at our center. This may be due to higher motivation (action vs. precontemplation or contemplation stage) in the intervention group compared to the control group. Earlier studies indicate that participants in action stage were over twice more likely than contemplative class members to be in drug treatment network.
This study has several limitations. One and the important foremost bias is difficult to implement a double blind. As the same investigator was involved in the application of the session and assessment part. However, this could be considering the prototype of the study which incorporate the screening with ASSIST and BI at the work up. The result also highlighted the feasibility and favorable outcome to reduce the risky pattern of substance use in work place setting. The short duration of study limits drawing conclusions over a longer period of time. There was no laboratory corroboration of the participants’ substance use, which was entirely based on self-report. Finally, only male hospital employees were recruited for this study as there was no published study which highlighted the prevalence of substance use in female employees at workplace in Indian context. The recently conducted largest national-level epidemiological study in India demonstrated that the prevalence figures of use of alcohol, cannabis, and other illicit substances in males and females were 27.3 and 1.6, 5 and 0.6, and 4 and 0.2, respectively. Thus, the prevalence of substance use is much less in females as compared to males in India. However, we believe that these limitations do not invalidate the main findings of this study within the constraints of generalizability.
In conclusion, this study demonstrates that ASSIST-based screening for risky substance use, and ASSIST-linked brief intervention is feasible in the workplace settings in developing countries such as India, and that this brief intervention is effective in reducing risk scores for use of several substances (alcohol, tobacco, and cannabis), progression in the readiness to change to an action stage, improving the QOL in all domains, and fostering help-seeking when needed.
The study protocol was approved by the Institutional Ethics Committee (INT/IEC/2015/739 dated 10.20.2015) and was registered with the Clinical Trials Registry of India [(http://ctri.nic.in) CTRI/2015/11/006365 dated 11.17.2016]. It followed the ethical standards of the responsible committee on human experimentations with informed consent of all the participants.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
1. Murthy P. Partnerships for Drug Demand Reduction in India: Developing Community Drug Rehabilitation and Workplace Prevention Programmes. United Nations Drug Control Programme, Ministry of Social Justice and Empowerment, Government of India, International Labour Organization, European Commission; 2002. Available from: https://www. unodc.org/pdf/india/Partnerships%20808%20Report.pdf
. [Last accessed on 2022 Dec 14].
2. Humeniuk RE, Dennington V, Ali RL. The Effectiveness of a Brief Intervention
for Illicit Drugs Linked to the ASSIST Screening
Test in Primary Health Care settings: A Technical Report of Phase III Findings of the WHO ASSIST
Randomised Controlled Trial. Geneva: World Health Organization; 2008.
3. Miller WR, Rollnick S. Motivational Interviewing:Preparing People for Change. 2nd
ed. New York: The Guilford Press; 2002.
4. Prochaska JA, DiClemente CC. Transtheoretical therapy:Towards a more integrative model of change. Psychotherapy 1982;19:276–88.
5. Gryczynski IJ, Mitchell SG, Peterson TR, Gonzales A, Moseley A, Schwartz RP. The relationship between services delivered and substance use outcomes in New Mexico's Screening
, Brief Intervention
, Referral and Treatment (SBIRT) Initiative. Drug Alcohol Depend 2011;118:152–7.
6. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend 2005;77:49–59.
7. Mitchell GS, Gryczynski J, Gonzales A. Screening
, brief intervention
, and referral to treatment (SBIRT) for substance use in a school-based program:Services and outcomes. Am J Addict 2012;21:S5–13.
8. Bertha KM, Compton WC, Avula D, Stegbauer T, Stein JB, Clark HW. Screening
, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites:Comparison at intake and six months. Drug Alcohol Depend 2009;99:280–95.
9. Saunders B, Wilkinson C, Phillips M. The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction 1995;90:415–24.
10. Baer JS, Garrett SB, Beadnell B, Wells EA, Peterson PL. Brief motivational intervention with homeless adolescents:Evaluating effects on substance use and service utilization. Psychol Addict Behav 2007;21:582–6.
11. Richmond R, Kehoe L, Heather N, Wodak A. Evaluation of a workplace brief intervention
for excessive alcohol consumption:The work screen project. Prev Med 2000;30:51–63.
12. Zibe Piegel VP, Boerngen Lacerda R. How to detect early harmful and hazardous substance use in workplace:A qualitative study. J Alcoholism Drug Depend 2013;1:104.
13. Hermansson U, Helander A, Brandt L, Huss A, Ronnberg S. Screening
and brief intervention
for risky alcohol consumption in the workplace:Results of a 1 year randomised controlled study. Alcohol Alcohol 2010;45:252–7.
14. Watson H, Godfrey C, McFadyen A, McArthur K, Stevenson M, Holloway A. Reducing alcohol-related harm in the workplace a feasibility study of screening
and brief interventions for hazardous drinkers. Int J Nursing Studies 2012.
15. Humeniuk R, Ali R, Babor T. A randomized controlled trial
of a brief intervention
for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening
) in clients recruited from primary health-care settings in four countries. Addiction 2012;107:957–66.
16. Joseph J, Das K, Sharma S, Basu D. ASSIST
-linked alcohol screening
and brief intervention
in Indian workplace setting:Result of a 4-month follow up. Indian J Soc Psychiatry 2014;30:80–6.
17. Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M. The ASSIST
-linked brief intervention
for hazardous and harmful substance use:manual for use in primary care, Geneva, World Health Organization; 2010.
18. Heather N, Rollnick S. Readiness to Change Questionnaire:User's Manual (revised version). Canberra: National Drug and Alcohol Research Centre; 1993.
19. Saxena S, Chaniramani K, Bhargava R. WHOQOL-Hindi:A questionnaire for assessing quality of life in health care settings in India. Natl Med J India 1998;11:160–5.
20. Caulking JP, Hawken A, Kilmer B, Kleiman MAR. Marijuana Legalization:What Everyone Needs to Know. New York, Oxford University Press; 2012.
21. Chagas SM, Gaunekar G, Patel V, Kukalekar DS, Fernandes J. The prevalence and correlates of hazardous drinking in industrial workers:A community study from Goa India. Alcohol Alcohol 2003;38:79–83.
22. Satija DC, Khatri JS, Satija YK, Nathawat SS. A study of prevalence and patterns of drug abuse in industrial workers. Int J Soc Psychiatry 1997;13:47–52.
23. Hale D, Viner R. Trends in the prevalence of multiple substance use in adolescents in England, 1998-2009. J Public Health (Oxf) 2013;35:367–74.
24. Wagner FA, Anthony JC. Into the world of illegal drug use:Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol 2002;155:918–25.
25. Pal HR, Yadav D, Mehta S, Mohan IA. Comparison of brief intervention
versus simple advice for alcohol use disorders in a North India community-based sample followed for 3 months. Alcohol Alcohol 2007;42:328–32.
26. Pengpid S, Peltzer K, Puckpinyo A. Screening
and concurrent brief intervention
of conjoint hazardous or harmful alcohol and tobacco use in hospital out-patients in Thailand:A randomized controlled trial
. Subst Abuse Treat Prev Policy 2015;10:22.
27. Assanangkornchai S, Balthip Q, Edwards JG. Implementing the Alcohol, Smoking, Substance Involvement Screening
Test and linked brief intervention
service in primary care in Thailand. J Public Health 2014;36:443–9.
28. Saitz R, Palfai PA, Cheng DM. Screening
and brief intervention
for drug use in primary care. The ASPIRE randomized clinical trial. JAMA 2014;312:502–13.
29. Loretta L, Denering MS, Suzanne ES. Routine use of screening
and brief intervention
for college students in a university counseling center. J Psychoactive Drugs 2012;44:318–24.
30. Williams S, Brown A, Patton R, Crawford MJ, Touquet R. The half-life of the 'teachable moment'for alcohol misusing patients in the emergency department. Drug Alcohol Depend 2005;77:205–8.
31. Miller WR, Sanchez MC. Motivating young adults for treatment and lifestyle change Howard G Issues in Alcohol Use and Misuse by Young Adults. Notre Dame: University of Notre Dame Press; 1994: 55–82.
32. Wilk AI, Jensen NM, Havighurst TC. Meta analysis of randomised control trails addressing brief intervention
in heavy alcohol drinker. J Intern Med 1997;12:274–83.
33. Merrick ES, Volpe-Vartanian J, Horgan CM, McCann B. Alcohol and drug abuse:Revisiting employee assistance programs and substance use problems in the workplace:Key issues and a research agenda. Psychiatr Serv 2007;58:1262–4.
34. Harrella PT, Trenzb RC, Scherera M, Martinsc SS, Latimerd WW. A latent class approach to treatment readiness corresponds to transtheoretical (“stages of change”) model. J Subst Abuse Treat 2013;45:249–56.
35. Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK. On behalf of the group of investigators for the National Survey on Extent and Pattern of Substance Use in India. Magnitude of Substance Use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India; 2019.